Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between Plasmodium vivax PvDBP and Plasmodium falciparum VAR2CSA.

Mitran CJ, Mena A, Gnidehou S, Banman S, Arango E, Lima BAS, Lugo H, Ganesan A, Salanti A, Mbonye AK, Ntumngia F, Barakat K, Adams JH, Kano FS, Carvalho LH, Maestre AE, Good MF, Yanow SK.

MBio. 2019 Oct 8;10(5). pii: e02343-19. doi: 10.1128/mBio.02343-19.

2.

Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals.

Rodríguez-Osorio I, Mena A, Meijide H, Morano L, Delgado M, Cid P, Margusino L, Pedreira JD, Castro Á.

PLoS One. 2019 Jun 3;14(6):e0217052. doi: 10.1371/journal.pone.0217052. eCollection 2019.

3.

Effectiveness of fentanyl pectin nasal citrate in controlling episodes of breakthrough cancer pain triggered by routine radiotherapy procedures.

Pardo J, Mena A, Jiménez E, Aymar N, Ortiz I, Roncero R, Mestre F, Vidal M.

Clin Transl Oncol. 2019 May 15. doi: 10.1007/s12094-019-02125-8. [Epub ahead of print]

PMID:
31093890
4.

Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus.

Cachay ER, Mena A, Morano L, Benitez L, Maida I, Ballard C, Hill L, Torriani F, Castro A, Dore E, Castro S, de Mendoza Fernández C, Soriano V, Mathews WC; HCV-TREN Cohort.

Open Forum Infect Dis. 2019 Feb 11;6(3):ofz070. doi: 10.1093/ofid/ofz070. eCollection 2019 Mar.

5.

Clinical and epidemiological impact of varicella infection in children prior to the introduction of the varicella vaccine in the national immunization schedule of Argentina.

Neyro SE, Ferolla FM, Molise C, Stach P, Romano P, Marone S, de Mena A, Plat F, Voto C, Soto P, Bustos L, Clavijo C, Murgo D, Dozoretz D, Fiorentino J, Lopez EL.

Arch Argent Pediatr. 2019 Feb 1;117(1):12-18. doi: 10.5546/aap.2019.eng.12. English, Spanish.

6.

Darunavir/cobicistat maintains the effectiveness of darunavir/ritonavir in HIV-infected patients under mono or dual therapy.

Mena Á, Cid P, Dueñas C, Garcinuño MÁ, Lorenzo JF, Margusino L, Quiñones M, Grande C, Rodríguez-Osorio I, Castro Á.

HIV Clin Trials. 2018 Oct;19(5):197-201. doi: 10.1080/15284336.2018.1513974. Epub 2019 Jan 3.

PMID:
30605006
7.

Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection.

Suárez-Bode L, Barrón R, Pérez JL, Mena A.

Anaerobe. 2019 Feb;55:124-129. doi: 10.1016/j.anaerobe.2018.12.002. Epub 2018 Dec 11.

PMID:
30550807
8.

Cross-Species Immune Recognition Between Plasmodium vivax Duffy Binding Protein Antibodies and the Plasmodium falciparum Surface Antigen VAR2CSA.

Gnidehou S, Mitran CJ, Arango E, Banman S, Mena A, Medawar E, Lima BAS, Doritchamou J, Rajwani J, Jin A, Gavina K, Ntumngia F, Duffy P, Narum D, Ndam NT, Nielsen MA, Salanti A, Kano FS, Carvalho LH, Adams JH, Maestre A, Good MF, Yanow SK.

J Infect Dis. 2019 Jan 1;219(1):110-120. doi: 10.1093/infdis/jiy467.

PMID:
30534974
9.

Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users.

Pineda JA, Climent B, García F, García Deltoro M, Granados R, Gómez F, Macías J, Mena Á, Merchante N, Ochoa E, Roncero C, Ruiz JJ, Téllez F, Morano L.

Enferm Infecc Microbiol Clin. 2018 Nov 8. pii: S0213-005X(18)30266-0. doi: 10.1016/j.eimc.2018.09.006. [Epub ahead of print] English, Spanish.

PMID:
30415884
10.

Conditioned increase of locomotor activity induced by haloperidol.

De la Casa LG, Cárcel L, Ruiz-Salas JC, Vicente L, Mena A.

PLoS One. 2018 Oct 3;13(10):e0200178. doi: 10.1371/journal.pone.0200178. eCollection 2018.

11.

[The design of a population register on cerebral palsy: its application and analysis in Andorra and Navarre].

Avellanet M, Mena A, Aisa-Pardo E.

Rev Neurol. 2018 Sep 1;67(5):168-174. Spanish.

12.

Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategies.

Grandal M, Pernas B, Tabernilla A, Mariño A, Álvarez H, Valcarce N, Mena A, Castro-Iglesias A, Pérez AB, Delgado M, Poveda E.

J Med Virol. 2018 Jun;90(6):1094-1098. doi: 10.1002/jmv.25048. Epub 2018 Mar 12.

PMID:
29427437
13.

Asymmetric cell division requires specific mechanisms for adjusting global transcription.

Mena A, Medina DA, García-Martínez J, Begley V, Singh A, Chávez S, Muñoz-Centeno MC, Pérez-Ortín JE.

Nucleic Acids Res. 2017 Dec 1;45(21):12401-12412. doi: 10.1093/nar/gkx974.

14.

The implementation of the Plan Esperanza and response to the imPACT Review.

Vidaurre T, Santos C, Gómez H, Sarria G, Amorin E, López M, Regalado R, Manrique J, Tarco D, Ayestas C, Calderón M, Mas L, Neciosup S, Salazar M, Chávez JC, Ubillus M, Limache A, Ubillus JC, Navarro J, Sarwal K, Sutcliffe S, Gutiérrez-Aguado A, Silva M, Mena A, Guillén ME, Castañeda C, Abugattas J.

Lancet Oncol. 2017 Oct;18(10):e595-e606. doi: 10.1016/S1470-2045(17)30598-3. Review.

PMID:
28971826
15.

Plasma mitochondrial DNA levels are inversely associated with HIV-RNA levels and directly with CD4 counts: potential role as a biomarker of HIV replication.

Pernas B, Rego-Pérez I, Tabernilla A, Balboa V, Relaño S, Grandal M, Crespo M, Mena Á, Castro-Iglesias Á, Blanco FJ, Poveda E.

J Antimicrob Chemother. 2017 Nov 1;72(11):3159-3162. doi: 10.1093/jac/dkx272.

PMID:
28961892
16.

Reward devaluation disrupts latent inhibition in fear conditioning.

De la Casa LG, Mena A, Ruiz-Salas JC, Quintero E, Papini MR.

Learn Behav. 2018 Mar;46(1):49-59. doi: 10.3758/s13420-017-0282-1.

PMID:
28699100
17.

[Payment mechanisms and financial resources management for consolidation of Ecuador's health system].

Villacrés T, Mena AC.

Rev Panam Salud Publica. 2017 Jun 8;41:e51. Review. Spanish.

18.

[Cervicofacial actinomycosis as differential diagnosis of cavum carcinoma: case report].

Anteliz García ET, Carballo CM, Estévez S, Diana S, de Mena A, Manonelles G, Cazes CI, López EL.

Arch Argent Pediatr. 2017 Jun 1;115(3):e166-e169. doi: 10.5546/aap.2017.e166. Spanish.

19.

Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected.

Meijide H, Pértega S, Rodríguez-Osorio I, Castro-Iglesias Á, Baliñas J, Rodríguez-Martínez G, Mena Á, Poveda E.

AIDS. 2017 May 15;31(8):1099-1107. doi: 10.1097/QAD.0000000000001448.

PMID:
28441174
20.

Short article: Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: impact for monitoring and optimizing treatment duration.

Tabernilla A, Grandal M, Pernas B, Castro-Iglesias A, Rodríguez-Osorio I, Mena A, Delgado M, Cid P, Pedreira JD, Poveda E.

Eur J Gastroenterol Hepatol. 2017 Jul;29(7):781-785. doi: 10.1097/MEG.0000000000000882.

PMID:
28410351
21.

Validation of heart failure diagnosis registered in primary care records in two primary care centres in Barcelona (Spain) and factors related. A cross-sectional study.

Verdú-Rotellar JM, Frigola-Capell E, Alvarez-Pérez R, da Silva D, Enjuanes C, Domingo M, Mena A, Muñoz MA.

Eur J Gen Pract. 2017 Dec;23(1):107-113. doi: 10.1080/13814788.2017.1305104.

22.

Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.

Mena A, Meijide H, Rodríguez-Osorio I, Castro A, Poveda E.

HIV Med. 2017 Oct;18(9):685-689. doi: 10.1111/hiv.12502. Epub 2017 Feb 23.

23.

Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patients.

Rodríguez-Osorio I, Cid P, Morano L, Castro Á, Suárez M, Delgado M, Margusino L, Meijide H, Pernas B, Tabernilla A, Pedreira JD, Mena Á, Poveda E.

J Clin Virol. 2017 Mar;88:58-61. doi: 10.1016/j.jcv.2017.01.003. Epub 2017 Jan 18.

PMID:
28183063
24.

Influence of Core Affect in the Differential Efficacy of a Personality Disorder Intervention Program.

Ramos JM, Sendra JM, Sánchez A, Mena A.

Span J Psychol. 2017 Feb 6;20:E5. doi: 10.1017/sjp.2017.2.

PMID:
28162134
25.

Characterization of chronic HCV infection in Northwest Spain: Impact of the treatment strategic plan of the Spanish National Health Service on HCV cure.

Grandal M, Pernas B, Mariño A, Álvarez H, Tabernilla A, Castro-Iglesias Á, Mena Á, Delgado M, Pértega S, Poveda E.

J Med Virol. 2017 Jul;89(7):1304-1308. doi: 10.1002/jmv.24766. Epub 2017 Mar 14.

PMID:
28079256
26.

Cancer Incidence in Persons Living With HIV.

Meijide H, Mena Á, Rodríguez-Osorio I, Castro-Iglesias Á, Poveda E.

Clin Infect Dis. 2017 Feb 1;64(3):388-389. doi: 10.1093/cid/ciw759. Epub 2016 Nov 14. No abstract available.

PMID:
28013260
27.

Reduced Prepulse Inhibition as a Biomarker of Schizophrenia.

Mena A, Ruiz-Salas JC, Puentes A, Dorado I, Ruiz-Veguilla M, De la Casa LG.

Front Behav Neurosci. 2016 Oct 18;10:202. eCollection 2016.

28.

Trends in hospital admissions, re-admissions, and in-hospital mortality among HIV-infected patients between 1993 and 2013: Impact of hepatitis C co-infection.

Meijide H, Mena Á, Rodríguez-Osorio I, Pértega S, Castro-Iglesias Á, Rodríguez-Martínez G, Pedreira J, Poveda E.

Enferm Infecc Microbiol Clin. 2017 Jan;35(1):20-26. doi: 10.1016/j.eimc.2016.07.012. Epub 2016 Sep 5.

PMID:
27609631
29.

Effect of stress and attention on startle response and prepulse inhibition.

De la Casa LG, Mena A, Ruiz-Salas JC.

Physiol Behav. 2016 Oct 15;165:179-86. doi: 10.1016/j.physbeh.2016.07.022. Epub 2016 Jul 30.

PMID:
27484698
30.

Lung Cancer in HIV-Infected Patients.

Mena Á, Meijide H, Marcos PJ.

AIDS Rev. 2016 Jul-Sep;18(3):138-144. Review.

PMID:
27438573
31.

A Quantitative Analysis of Cold Water for Human Consumption in Hospitals in Spain.

González AG, García-Sanz-Calcedo J, Salgado DR, Mena A.

J Healthc Eng. 2016;2016. doi: 10.1155/2016/6534823.

32.

Brief Report: European Mitochondrial Haplogroups Impact on Liver Fibrosis Progression Among HCV and HIV/HCV-Coinfected Patients From Northwest Spain.

Tabernilla A, Rego-Pérez I, Grandal M, Pernas B, Pértega S, Delgado M, Mariño A, Álvarez H, Mena A, Rodríguez-Osorio I, Pedreira JD, Blanco FJ, Poveda E.

J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):149-53. doi: 10.1097/QAI.0000000000001097.

PMID:
27258234
33.

Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in Spain.

Pernas B, Grandal M, Tabernilla A, Cid P, Pértega S, Castro-Iglesias Á, Mena Á, Margusino L, Pedreira JD, Poveda E.

J Med Virol. 2016 Dec;88(12):2125-2131. doi: 10.1002/jmv.24585. Epub 2016 Jun 6.

PMID:
27218208
34.

mRNA PGC-1α levels in blood samples reliably correlates with its myocardial expression: study in patients undergoing cardiac surgery.

Fabregat-Andres O, Paredes F, Monsalve M, Milara J, Ridocci-Soriano F, Gonzalez-Hervas S, Mena A, Facila L, Hornero F, Morell S, Martinez-Leon J, Cortijo J.

Anatol J Cardiol. 2016 Aug;16(8):622-629. doi: 10.5152/AnatolJCardiol.2015.6466. Epub 2015 Nov 26.

35.

[Prevalence and intensity of infection by soil-transmitted helminths and prevalence of malaria among schoolchildren in El Salvador].

Sorto ÓR, Portillo AM, Aragón MÁ, Saboyá MI, Ade MP, Minero MÁ, Hernández MA, Mena AG, Peña R, Mejía VM, Carter K.

Biomedica. 2015 Jul-Sep;35(3):407-18. doi: 10.7705/biomedica.v35i3.2408. Spanish.

36.

Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?

Pernas B, Grandal M, Pertega S, Cañizares A, Castro-Iglesias Á, Mena Á, Rodriguez-Osorio I, Tabernilla A, Pedreira JD, Poveda E.

J Antimicrob Chemother. 2016 Apr;71(4):1051-5. doi: 10.1093/jac/dkv433. Epub 2015 Dec 24.

PMID:
26702924
37.

Lung cancer in patients living with HIV infection.

Meijide H, Mena A, Marcos PJ, Rodriguez-Osorio I, Suárez-Fuentetaja R, Castro A, Poveda E, Pedreira JD.

AIDS. 2015 Nov;29(17):2363-4. doi: 10.1097/QAD.0000000000000840. No abstract available.

PMID:
26544707
38.

Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin.

Monje-Agudo P, Castro-Iglesias A, Rivero-Juárez A, Martínez-Marcos F, Ortega-González E, Real LM, Pernas B, Merchante N, Cid P, Macías J, Merino MD, Rivero A, Mena A, Neukam K, Pineda JA; Grupo de Estudio de Hepatitis Vírica, of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica.

Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):1929-36. doi: 10.1007/s10096-015-2434-6. Epub 2015 Jul 9.

PMID:
26155784
39.

Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.

Casado JL, Mena A, Bañón S, Castro A, Quereda C, Moreno A, Pedreira J, Moreno S.

HIV Med. 2016 Jan;17(1):62-7. doi: 10.1111/hiv.12274. Epub 2015 Jun 30.

40.

An experience of liver transplantation in Latin America: a medical center in Colombia.

Santos O, Londoño M, Marín J, Muñoz O, Mena Á, Guzmán C, Hoyos S, Restrepo J, Arbeláez M, Correa G.

Colomb Med (Cali). 2015 Mar 30;46(1):8-13. eCollection 2015 Jan-Mar.

41.

A survey of intestinal parasites including associated risk factors in humans in Panama.

Sandoval NR, Ríos N, Mena A, Fernández R, Perea M, Manzano-Román R, Santa-Quiteria JA, Hernández-Gonzalez A, Siles-Lucas M.

Acta Trop. 2015 Jul;147:54-63. doi: 10.1016/j.actatropica.2015.03.024. Epub 2015 Mar 28.

PMID:
25823566
42.

Trends on epidemiological, virological, and clinical features among newly diagnosed HIV-1 persons in Northwest Spain over the last 10 years.

Pernas B, Mena A, Cañizares A, Grandal M, Castro-Iglesias A, Pértega S, Pedreira JD, Poveda E.

J Med Virol. 2015 Aug;87(8):1319-26. doi: 10.1002/jmv.24185. Epub 2015 Mar 16.

PMID:
25777786
43.

Evolutionary Advantage Conferred by an Eukaryote-to-Eukaryote Gene Transfer Event in Wine Yeasts.

Marsit S, Mena A, Bigey F, Sauvage FX, Couloux A, Guy J, Legras JL, Barrio E, Dequin S, Galeote V.

Mol Biol Evol. 2015 Jul;32(7):1695-707. doi: 10.1093/molbev/msv057. Epub 2015 Mar 6.

44.

Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: a retrospective multicenter case-control study.

Clemente W, Vidal E, Girão E, Ramos AS, Govedic F, Merino E, Muñoz P, Sabé N, Cervera C, Cota GF, Cordero E, Mena A, Montejo M, López-Medrano F, Aguado JM, Fernandes P, Valerio M, Carratalá J, Moreno A, Oliveira J, Mourão PH, Torre-Cisneros J.

Clin Microbiol Infect. 2015 Jan;21(1):89-95. doi: 10.1016/j.cmi.2014.09.002. Epub 2014 Oct 12.

45.

Factors associated with recurrence and survival in liver transplant patients with HCC--a single center retrospective study.

Hoyos S, Escobar J, Cardona D, Guzmán C, Mena Á, Osorio G, Pérez C, Restrepo JC, Correa G.

Ann Hepatol. 2015 Jan-Feb;14(1):58-63.

46.

Molecular characterization of HIV-1 infection in Northwest Spain (2009-2013): Investigation of the subtype F outbreak.

Paraskevis D, Kostaki E, Beloukas A, Cañizares A, Aguilera A, Rodríguez J, Grandal M, Pernas B, Castro-Iglesias A, Mena Á, Pedreira JD, Poveda E.

Infect Genet Evol. 2015 Mar;30:96-101. doi: 10.1016/j.meegid.2014.12.012. Epub 2014 Dec 16.

PMID:
25527396
47.

Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing.

Mena A, Moldes L, Meijide H, Cañizares A, Castro-Iglesias A, Delgado M, Pértega S, Pedreira J, Bou G, Poveda E.

PLoS One. 2014 Dec 1;9(12):e113062. doi: 10.1371/journal.pone.0113062. eCollection 2014.

48.

Efficacy and safety of etravirine-containing regimens in a large cohort of HIV/HCV coinfected patients according to liver fibrosis.

Casado JL, Mena A, Bañón S, Moreno A, Castro A, Perez-Elías MJ, Pedreira J, Moreno S.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19574. doi: 10.7448/IAS.17.4.19574. eCollection 2014.

49.

Update on hepatitis C virus resistance to direct-acting antiviral agents.

Poveda E, Wyles DL, Mena A, Pedreira JD, Castro-Iglesias A, Cachay E.

Antiviral Res. 2014 Aug;108:181-91. doi: 10.1016/j.antiviral.2014.05.015. Epub 2014 Jun 6. Review. Erratum in: Antiviral Res. 2014 Nov;111:154.

PMID:
24911972
50.

High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response.

Pernas B, Grandal M, Mena A, Castro-Iglesias A, Cañizares A, Wyles DL, López-Calvo S, Pértega S, Rodríguez-Osorio I, Pedreira JD, Poveda E.

AIDS. 2014 Jul 31;28(12):1837-40. doi: 10.1097/QAD.0000000000000326.

PMID:
24871456

Supplemental Content

Support Center